Imprivata Coverage Initiated by Analysts at JPMorgan Chase & Co. (IMPR)
Analysts at JPMorgan Chase & Co. assumed coverage on shares of Imprivata (NASDAQ:IMPR) in a research report issued to clients and investors on Monday, TheFlyOnTheWall.com reports. The firm set an “overweight” rating and a $19.00 price target on the stock. JPMorgan Chase & Co.’s price objective suggests a potential upside of 18.53% from the stock’s previous close.
Imprivata (NASDAQ:IMPR) traded down 3.45% during mid-day trading on Monday, hitting $15.97. 24,837 shares of the company’s stock traded hands. Imprivata has a one year low of $15.40 and a one year high of $17.49. The stock’s 50-day moving average is $16.24 and its 200-day moving average is $16.24. The company’s market cap is $364.4 million.
Separately, analysts at Piper Jaffray initiated coverage on shares of Imprivata in a research note on Monday. They set an “overweight” rating and a $20.00 price target on the stock.
Imprivata Inc is a provider of authentication and access management technology solutions for the healthcare industry.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.